Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Nara, Japan Clinical Trials

A listing of Nara, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (1) clinical trials

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

This is a Phase 1, multicenter, open-label study to evaluate safety, tolerability and pharmacokinetics of milademetan in Japanese patients with relapsed or refractory acute myeloid leukemia. The milademetan initial dose will be Level 1: 90 mg. No increase in the milademetan dose will be made in the same participant. Dose-limiting ...

Phase

6.01 miles

Learn More »